News Medical on MSN16h
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
The seven types of cancer linked to drinking alcohol
The World Health Organisation (WHO) is calling for cigarette-style warnings on alcohol to raise awareness about the link ...